project id: TCGA-CESC; case submitter id: TCGA-EK-A2R8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.5; age at index: 48; days to birth: -17692; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 17692; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic t: T1b2; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 44.0; figo stage: Stage IB2; icd 10 code: C53.9; last known disease status: not reported; morphology: 8072/3; primary diagnosis: Squamous cell carcinoma, large cell, nonkeratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cervix uteri; synchronous malignancy: No; tissue or organ of origin: Cervix uteri; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 554; initial weight: 100.0; oct embedded: false; preservation method: Unknown; sample id: 6b8e0af3-1632-4fed-9a37-879ea013ae24; sample submitter id: TCGA-EK-A2R8-01A; portion id: 2b2e558d-81cf-4e7c-892f-278567149cc5; portion submitter id: TCGA-EK-A2R8-01A-21; slide id: b52e8672-872b-4596-acf9-bc83a37e6b9d; slide submitter id: TCGA-EK-A2R8-01A-02-TS2; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 25.0; percent normal cells: 2.0; percent stromal cells: 5.0; percent tumor cells: 78.0; percent tumor nuclei: 65.0; section location: TOP;